Pharming Group N.V. SEC filings PHAR

Pharming Group N.V. has 149 filings in SEC EDGAR's recent list, going back to Oct 14, 2020. Its latest annual report, Form 20-F, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 6, 2026. The company's fiscal year ends on December 31.

Pharming Group N.V. SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Nov 6, 2026 Nov 6, 2026
6-K Current report (foreign issuer) Oct 27, 2026 Oct 27, 2026
6-K Current report (foreign issuer) Oct 22, 2026 Oct 22, 2026
6-K Current report (foreign issuer) Oct 14, 2026 Oct 14, 2026
6-K Current report (foreign issuer) Sep 29, 2026 Sep 29, 2026
6-K Current report (foreign issuer) Sep 25, 2026 Sep 25, 2026
6-K Current report (foreign issuer) Sep 22, 2026 Sep 22, 2026
6-K Current report (foreign issuer) Sep 11, 2026 Sep 11, 2026
6-K Current report (foreign issuer) Aug 13, 2026 Aug 13, 2026
6-K Current report (foreign issuer) Jul 30, 2026 Jul 30, 2026
6-K Current report (foreign issuer) Jun 4, 2026 Jun 4, 2026
6-K Current report (foreign issuer) May 28, 2026 May 28, 2026
6-K Current report (foreign issuer) May 22, 2026 May 22, 2026
6-K Current report (foreign issuer) May 7, 2026 May 7, 2026
6-K Current report (foreign issuer) May 7, 2026 May 7, 2026
6-K Current report (foreign issuer) Apr 16, 2026 Apr 16, 2026
20-F/A Amended annual report (foreign issuer) Apr 13, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Apr 2, 2026 Apr 2, 2026
20-F Annual report (foreign issuer) Apr 2, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Mar 27, 2026 Mar 27, 2026
6-K Current report (foreign issuer) Mar 24, 2026 Mar 24, 2026
6-K Current report (foreign issuer) Mar 12, 2026 Mar 12, 2026
6-K Current report (foreign issuer) Feb 3, 2026 Feb 3, 2026
6-K Current report (foreign issuer) Feb 2, 2026 Feb 1, 2026
6-K Current report (foreign issuer) Jan 8, 2026 Jan 8, 2026
6-K Current report (foreign issuer) Nov 6, 2025 Nov 6, 2025
6-K Current report (foreign issuer) Oct 22, 2025 Oct 20, 2025
6-K Current report (foreign issuer) Oct 6, 2025 Oct 6, 2025
6-K Current report (foreign issuer) Oct 1, 2025 Oct 1, 2025
6-K Current report (foreign issuer) Sep 10, 2025 Sep 10, 2025
6-K Current report (foreign issuer) Sep 2, 2025 Sep 2, 2025
6-K Current report (foreign issuer) Jul 31, 2025 Jul 31, 2025
6-K Current report (foreign issuer) Jun 24, 2025 Jun 24, 2025
6-K Current report (foreign issuer) Jun 11, 2025 Jun 11, 2025
6-K Current report (foreign issuer) May 8, 2025 May 8, 2025
6-K Current report (foreign issuer) Apr 30, 2025 Apr 30, 2025
6-K Current report (foreign issuer) Apr 25, 2025 Apr 25, 2025
6-K Current report (foreign issuer) Apr 23, 2025 Apr 23, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 7, 2025 —
6-K Current report (foreign issuer) Apr 3, 2025 Apr 3, 2025
20-F Annual report (foreign issuer) Apr 3, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Mar 20, 2025 Mar 20, 2025
6-K Current report (foreign issuer) Mar 13, 2025 Mar 13, 2025
6-K Current report (foreign issuer) Mar 4, 2025 Mar 4, 2025
6-K Current report (foreign issuer) Feb 20, 2025 Feb 20, 2025
6-K Current report (foreign issuer) Feb 7, 2025 Feb 7, 2025
6-K Current report (foreign issuer) Jan 21, 2025 Jan 21, 2025
6-K Current report (foreign issuer) Jan 21, 2025 Jan 21, 2025
6-K Current report (foreign issuer) Dec 16, 2024 Dec 15, 2024
6-K Current report (foreign issuer) Dec 11, 2024 Dec 11, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 8, 2024 —
6-K Current report (foreign issuer) Oct 24, 2024 Oct 24, 2024
6-K Current report (foreign issuer) Oct 10, 2024 Oct 10, 2024
6-K Current report (foreign issuer) Sep 26, 2024 Sep 26, 2024
6-K Current report (foreign issuer) Aug 1, 2024 Aug 1, 2024
6-K Current report (foreign issuer) May 30, 2024 May 30, 2024
6-K Current report (foreign issuer) May 21, 2024 May 21, 2024
6-K Current report (foreign issuer) May 15, 2024 May 15, 2024
6-K Current report (foreign issuer) May 8, 2024 May 8, 2024
6-K Current report (foreign issuer) Apr 25, 2024 Apr 25, 2024
6-K Current report (foreign issuer) Apr 24, 2024 Apr 24, 2024
6-K Current report (foreign issuer) Apr 8, 2024 Apr 8, 2024
6-K Current report (foreign issuer) Apr 4, 2024 Apr 4, 2024
20-F Annual report (foreign issuer) Apr 4, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Mar 14, 2024 Mar 14, 2024
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
6-K Current report (foreign issuer) Jan 8, 2024 Jan 8, 2024
6-K Current report (foreign issuer) Dec 15, 2023 Dec 13, 2023
6-K Current report (foreign issuer) Nov 13, 2023 Nov 10, 2023
6-K Current report (foreign issuer) Oct 26, 2023 Oct 26, 2023
6-K Current report (foreign issuer) Sep 25, 2023 Sep 25, 2023
6-K Current report (foreign issuer) Aug 14, 2023 Aug 14, 2023
6-K Current report (foreign issuer) Aug 9, 2023 Aug 9, 2023
6-K Current report (foreign issuer) Aug 3, 2023 Aug 3, 2023
6-K Current report (foreign issuer) Jul 18, 2023 Jul 18, 2023
6-K Current report (foreign issuer) Jun 1, 2023 Jun 1, 2023
6-K Current report (foreign issuer) May 19, 2023 May 17, 2023
6-K Current report (foreign issuer) May 11, 2023 May 11, 2023
6-K Current report (foreign issuer) Apr 11, 2023 Apr 11, 2023
20-F Annual report (foreign issuer) Apr 5, 2023 Dec 31, 2022
6-K Current report (foreign issuer) Apr 5, 2023 Apr 5, 2023
6-K Current report (foreign issuer) Mar 27, 2023 Mar 24, 2023
6-K Current report (foreign issuer) Mar 16, 2023 Mar 16, 2023
6-K Current report (foreign issuer) Mar 13, 2023 Mar 13, 2023
6-K Current report (foreign issuer) Mar 13, 2023 Mar 12, 2023
6-K Current report (foreign issuer) Feb 21, 2023 Feb 21, 2023
6-K Current report (foreign issuer) Feb 17, 2023 Feb 16, 2023
6-K Current report (foreign issuer) Oct 27, 2022 Oct 27, 2022
6-K Current report (foreign issuer) Aug 4, 2022 Aug 4, 2022
6-K Current report (foreign issuer) Aug 2, 2022 Aug 2, 2022
6-K Current report (foreign issuer) Aug 1, 2022 Aug 1, 2022
6-K Current report (foreign issuer) Jun 2, 2022 Jun 2, 2022
6-K Current report (foreign issuer) May 18, 2022 May 18, 2022
6-K Current report (foreign issuer) May 12, 2022 May 12, 2022
6-K Current report (foreign issuer) May 5, 2022 May 5, 2022
6-K Current report (foreign issuer) Apr 26, 2022 Apr 26, 2022
6-K Current report (foreign issuer) Apr 22, 2022 Apr 22, 2022
6-K Current report (foreign issuer) Apr 6, 2022 Apr 6, 2022
20-F Annual report (foreign issuer) Apr 6, 2022 Dec 31, 2021
6-K Current report (foreign issuer) Apr 1, 2022 Apr 1, 2022
6-K Current report (foreign issuer) Mar 17, 2022 Mar 17, 2022
6-K Current report (foreign issuer) Mar 8, 2022 Mar 8, 2022
6-K Current report (foreign issuer) Feb 2, 2022 Feb 2, 2022
6-K Current report (foreign issuer) Jan 6, 2022 Jan 6, 2022
6-K Current report (foreign issuer) Jan 4, 2022 Dec 23, 2021
S-8 Employee stock plan registration Oct 28, 2021 —
6-K Current report (foreign issuer) Oct 28, 2021 Oct 28, 2021
6-K Current report (foreign issuer) Oct 22, 2021 Oct 22, 2021
6-K Current report (foreign issuer) Sep 14, 2021 Sep 14, 2021
6-K/A Filing Aug 9, 2021 Aug 5, 2021
6-K Current report (foreign issuer) Aug 5, 2021 Aug 5, 2021
6-K Current report (foreign issuer) Jul 20, 2021 Jul 20, 2021
6-K Current report (foreign issuer) Jul 1, 2021 Jul 1, 2021
6-K Current report (foreign issuer) Jun 24, 2021 Jun 23, 2021
6-K Current report (foreign issuer) Jun 21, 2021 Jun 18, 2021
6-K Current report (foreign issuer) Jun 4, 2021 Jun 4, 2021
6-K Current report (foreign issuer) Jun 1, 2021 Jun 1, 2021
6-K Current report (foreign issuer) May 19, 2021 May 19, 2021
6-K Current report (foreign issuer) May 17, 2021 May 17, 2021
6-K Current report (foreign issuer) May 13, 2021 May 13, 2021
6-K Current report (foreign issuer) Apr 22, 2021 Apr 22, 2021
20-F Annual report (foreign issuer) Apr 7, 2021 Dec 31, 2020
6-K Current report (foreign issuer) Apr 7, 2021 Apr 7, 2021
6-K Current report (foreign issuer) Apr 7, 2021 Apr 6, 2021
6-K Current report (foreign issuer) Mar 23, 2021 Mar 23, 2021
6-K Current report (foreign issuer) Mar 16, 2021 Mar 16, 2021
6-K Current report (foreign issuer) Mar 11, 2021 Mar 11, 2021
6-K Current report (foreign issuer) Mar 4, 2021 Dec 31, 2020
6-K Current report (foreign issuer) Mar 2, 2021 Mar 2, 2021
424B4 Prospectus Dec 23, 2020 —
6-K Current report (foreign issuer) Dec 23, 2020 Dec 22, 2020
EFFECT Filing Dec 22, 2020 —
EFFECT Filing Dec 22, 2020 —
SEC STAFF LETTER Filing Dec 22, 2020 —
CERT 8a cert Dec 22, 2020 —
F-1/A Filing Dec 22, 2020 —
CORRESP Letter to the SEC Dec 22, 2020 —
CORRESP Letter to the SEC Dec 22, 2020 —
8-A12B Filing Dec 21, 2020 —
CORRESP Letter to the SEC Dec 21, 2020 —
CORRESP Letter to the SEC Dec 17, 2020 —
F-1/A Filing Dec 17, 2020 —
F-6 Filing Dec 17, 2020 —
UPLOAD Letter from the SEC Dec 15, 2020 —
SEC STAFF LETTER Filing Dec 8, 2020 —
F-1 Registration statement (foreign issuer) Nov 25, 2020 —
UPLOAD Letter from the SEC Nov 12, 2020 —
DRS Filing Oct 14, 2020 —

Showing 149 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PHAR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Netherlands
Headquarters
Leiden, Netherlands
SEC filer status
Accelerated filer
SEC CIK
1828316

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.